EQUITY VALUATION · FRAMEWORK

DCF Valuation Framework: From Free Cash Flow to Intrinsic Value

Bottom Line — What DCF Is, What It Tells You, and Why Every Multiple Is a DCF Shortcut

A Discounted Cash Flow (DCF) model derives equity intrinsic value by projecting free cash flows over a 5–10 year horizon and adding a terminal value — both discounted at the weighted average cost of capital (WACC). Terminal value accounts for 60–80% of most DCF results, which means a 0.5% change in the terminal growth rate assumption moves intrinsic value by 15–20% in most models.

A 1% increase in WACC reduces NVIDIA's (NVDA) DCF intrinsic value by approximately 25%; the same WACC shift moves Coca-Cola (KO) by roughly 10%. Every valuation multiple investors use — P/E, EV/EBITDA, P/B — is an algebraic simplification of a full DCF under specific assumptions. The framework adapts by sector: tech equities (NVDA, MSFT, META) are terminal-value-dominated; financials (BX, KKR, GS) require dividend discount or excess-return models; healthcare (LLY, JNJ) incorporates pipeline NPV and patent-cliff sensitivity; defensives (KO, PG) anchor valuation in stable FCF with dividend yield as a valuation floor. Margin of safety — typically 15–20% for defensives and 30–40% for high-multiple growth equities — is the discipline that converts a DCF from an academic exercise into a repeatable investment process.

Anton Ladnyi — Founder & Portfolio Architect, A.L. Capital Advisory, ex-Goldman Sachs, CFA
Anton Ladnyi, CFA
Founder & Portfolio Architect — A.L. Capital Advisory
Ex-Goldman Sachs Equity Research · Ex-J.P. Morgan Wealth Management · CFA Charterholder
The Cliff Edge — DCF Intrinsic Value / Share vs WACC NVDA vs KO · Base assumptions May 2026 · ★ = analyst base case
The Cliff Edge — NVDA (TV=80%, g=2.5%) vs KO (TV=58%, g=2.0%): intrinsic value per share plotted against WACC, May 2026 $200 $160 $120 $80 $40 5% 6% 7% 8% 9% 10% 11% 12% 13% 14% WACC DEFENSIVE HIGH-GROWTH ★ $143 ★ $74 mkt $135 · impl. WACC ≈10.4% mkt $72 · impl. WACC ≈6.6% NVDA KO
NVDA — High-growth · TV=80% · Base WACC 10% · Base IV $143/sh
KO — Defensive · TV=58% · Base WACC 6.5% · Base IV $74/sh
★ Analyst base IV · Dashed lines = market price with implied WACC at intersection
60–80%Terminal value share of most equity DCF intrinsic values
~25%NVDA intrinsic value change per 1% WACC shift
15–20%Value change per 0.5% terminal growth rate move
30–40%Required margin of safety for high-multiple tech equities

What is a DCF model?

A Discounted Cash Flow model is the foundational method of equity valuation. The DCF model answers a precise question: what is a company worth today, given the cash flows the company is expected to generate in the future, adjusted for the time value of money and the risk inherent in those cash flows?

The mechanics are straightforward. An analyst projects a company's free cash flow to firm (FCFF) — operating cash flow minus capital expenditure, adjusted for working capital changes — over a forecast period of five to ten years. Beyond the forecast period, the analysis collapses into a single figure called the terminal value, which represents the present value of all cash flows the company is expected to generate in perpetuity after the forecast window closes. Both the explicit forecast-period cash flows and the terminal value are then discounted back to today using the WACC. The sum of those discounted values is the DCF intrinsic value of the enterprise. Subtract net debt to arrive at equity intrinsic value per share.

Core DCF Formula
Intrinsic Value = Σ [ FCFt / (1 + WACC)^t ] + Terminal Value / (1 + WACC)^n

Terminal Value (Gordon Growth) = FCF_final × (1 + g) / (WACC − g)

WACC = (E/V) × Re + (D/V) × Rd × (1 − Tax Rate)

Where: g = long-run terminal growth rate, Re = cost of equity (CAPM), Rd = cost of debt

The apparent simplicity of the formula conceals the majority of the analytical work. Every input — WACC, terminal growth rate, margin trajectory, capex intensity, tax rate — is an assumption. The DCF does not generate certainty. The DCF generates a structured framework for converting assumptions about the future into a present-value number, which can then be stress-tested against alternative scenarios. The discipline is not in running the model. The discipline is in stress-testing the assumptions and understanding which inputs the output is most sensitive to.

What is WACC and how does it affect a DCF valuation?

The WACC is the rate at which future cash flows are discounted back to the present. A higher WACC compresses intrinsic value — it reflects a higher required return demanded by capital providers. A lower WACC inflates intrinsic value. Because WACC appears in every denominator of the DCF formula, and because the terminal value denominator is (WACC − g), small changes in WACC produce disproportionately large changes in output — particularly for long-duration, high-multiple equities.

WACC has two components. The cost of equity (Re) is typically estimated using the Capital Asset Pricing Model: Re = Risk-Free Rate + Beta × Equity Risk Premium. In April 2026, with US 10-year Treasury yields near 4.3%, a standard equity risk premium of 5.0–5.5%, and sector-adjusted betas, cost-of-equity estimates for US large-cap equities range from approximately 8% (low-beta defensives) to 12–14% (high-beta growth). The cost of debt (Rd) is straightforward — the after-tax yield on the company's outstanding debt. Blended, these produce a WACC that reflects the firm's actual capital structure.

"The DCF does not predict the future. It makes assumptions explicit — so they can be challenged."

— Anton Ladnyi, CFA

WACC sensitivity is not uniform across sectors. For NVIDIA (NVDA) — a company whose intrinsic value is dominated by terminal-period assumptions about AI infrastructure adoption — a 1 percentage point increase in WACC reduces DCF intrinsic value by approximately 25%. The reason is mathematical: when terminal value represents 80%+ of total value, and when the terminal value denominator is (WACC − g), small numerator changes cascade. For Coca-Cola (KO), where near-term cash flows are stable and predictable and terminal value represents a smaller share of total value, a 1% WACC change moves intrinsic value by roughly 8–12%. This asymmetry is not a quirk — it is the structural argument for maintaining a larger margin of safety when valuing high-multiple growth equities.

What is terminal value in a DCF model, and why does it drive 60–80% of results?

Terminal value is the largest number in most DCF models, and the number most analysts underestimate the sensitivity of. In a standard 10-year DCF applied to an S&P 500 company with a WACC of 9% and a terminal growth rate of 3%, terminal value will typically account for 65–75% of total enterprise value. For a fast-growing technology company valued at 30–35× forward earnings — implying significant growth expected beyond a 10-year horizon — terminal value's share can exceed 80%.

Two inputs govern terminal value magnitude. First, the terminal growth rate (g): the assumed perpetual growth rate of free cash flow beyond the forecast period. Setting g above the long-run nominal GDP growth rate of 3.5–4.5% is theoretically problematic — a company cannot grow faster than the economy in perpetuity without eventually becoming the economy. In practice, sell-side models routinely embed terminal growth rates of 3–5%, with the upper end reserved for structurally advantaged businesses. A 0.5 percentage point change in g — from 3.0% to 3.5% — changes terminal value by approximately 15–20% in most standard models, everything else held constant.

Second, the terminal EBIT margin or FCF margin assumption embedded in the terminal year's FCF. Analysts who extrapolate current margin trajectories without questioning whether those margins are normalised or cyclically elevated build structural errors into the terminal value that no sensitivity table will reveal — because the sensitivity is typically run around the WACC and g inputs, not the terminal margin. The private equity industry's entry-multiple discipline is a practical acknowledgement of this problem: buying at 7–8.5× EV/EBITDA versus the 11× peak valuations of 2021 implicitly reflects a lower DCF intrinsic value embedded in that exit multiple, with terminal margin assumptions baked into the denominator.

How P/E, EV/EBITDA, and P/B relate to the DCF

Every valuation multiple used in equity research — P/E, EV/EBITDA, P/B, EV/Sales — is a compressed algebraic expression of a full DCF model under specific, usually implicit, assumptions. Understanding the relationship between multiples and DCF mechanics is what separates superficial valuation commentary from genuine analytical insight.

The price-to-earnings (P/E) ratio is the most widely cited multiple. A P/E of 20× implies an earnings yield of 5%, which corresponds to a DCF where WACC is approximately 9–10% and the terminal growth rate is in the 4–5% range — the remainder being a blended present-value weight of nearer-term earnings. When NVIDIA (NVDA) traded at 35–40× forward earnings in early 2026, the embedded DCF assumptions required either a substantially elevated terminal growth rate, a structurally lower discount rate (perhaps justified by NVDA's near-monopoly in AI training silicon), or both. When those assumptions become harder to defend — as interest rates rise and AI-infrastructure capex narratives mature — the P/E compresses even without a change in near-term earnings, because the market is repricing the implicit DCF inputs.

The EV/EBITDA multiple is most useful for capital-intensive industries where depreciation is a real economic cost (energy, industrials, real estate) and where debt levels vary significantly across peers. EV/EBITDA can be derived from a DCF by making explicit assumptions about the conversion from EBITDA to FCF: capex intensity, working capital, tax rate, and depreciation relative to maintenance capex. A 7× EV/EBITDA implies a DCF intrinsic value under one set of conversion assumptions; an 11× multiple implies the same EBITDA generating meaningfully higher intrinsic value under more optimistic FCF conversion or lower WACC assumptions. The private equity entry multiple discipline — referenced across the PE research — is a practical application of this equivalence: compressed entry multiples mechanically expand the DCF return available to the buyer.

The price-to-book (P/B) ratio is best understood through the excess-return framework. A P/B of 1× implies the market believes the company will earn its cost of equity — no more, no less. A P/B above 1× implies the market expects ROE to exceed the cost of equity over time, generating surplus economic value that compounds above book value. The Gordon Growth Model relationship — P/B = (ROE − g) / (ke − g) — makes explicit that P/B is simply a DCF applied to book value rather than free cash flow. Banks and asset managers are primarily valued on P/B because book value is the relevant base for financial intermediaries, and because the FCF concept does not translate cleanly to financial firms.

DCF by sector: four different models for four different businesses

The standard two-stage FCFF DCF is not universally appropriate. Different sector economics require different modelling approaches, all of which share the same present-value logic but differ in what they discount and how they define the "cash flow" available to equity holders.

Technology

Terminal-Value-Dominated DCF
For NVIDIA, Microsoft, and Meta, 75–85% of intrinsic value resides in terminal assumptions. High reinvestment rates and expanding TAMs make near-term FCF low relative to long-run potential. WACC sensitivity is acute: a 1% WACC move shifts NVDA's intrinsic value by ~25%. Margin-of-safety requirements are correspondingly higher — 30–40% discount to DCF central estimate is not conservative, it is disciplined.
75–85%TV / EV
9–12%WACC
30–40%Margin of Safety
NVDA · MSFT · META · GOOGL · AMZN

Financials & Alternatives

DDM / Excess-Return Model
Blackstone (BX), KKR, and Goldman Sachs (GS) cannot be valued with standard FCFF DCF — debt is an input to their business model, not a financing choice. Blackstone is best modelled on distributable earnings per unit (DE/unit) discounted at cost of equity. Goldman Sachs valuation anchors on P/B and the excess of ROE (15–18% normalised) over cost of equity (~11%), consistent with a Gordon-Growth excess-return framework.
DDMMethod
10–12%Cost of Equity
20–30%Margin of Safety
BX · KKR · GS · JPM · MS

Healthcare

Pipeline NPV + Patent-Cliff Sensitivity
Eli Lilly (LLY) and Johnson & Johnson (JNJ) require sum-of-the-parts DCF: each major drug asset is modelled individually with peak sales probability, phase-adjusted approval probability, launch timing, and patent expiry. LLY's valuation heavily reflects GLP-1 tirzepatide (Mounjaro) peak sales estimates of $40–60B by 2030. Patent cliffs create non-linear FCF breaks — generic entry can reduce a blockbuster's revenues by 80–90% within 24 months of loss of exclusivity.
SOTPMethod
8–10%WACC
~58%Phase III Rate
LLY · JNJ · ABBV · MRK · PFE

Defensives

Stable FCF, Low WACC, Dividend Floor
Coca-Cola (KO) and Procter & Gamble (PG) generate predictable, low-volatility free cash flow with modest reinvestment requirements. WACC sensitivity is the lowest of any sector — KO's intrinsic value moves ~8–12% per 1% WACC change. Dividend yield functions as a valuation floor: when KO's dividend yield approaches 3.5–4.0%, the market is implicitly embedding a DCF discount rate that leaves little equity risk premium, creating a natural support level tested repeatedly across market cycles.
KO · PG · JNJ · PEP · CL

Margin of safety: converting DCF outputs into investment decisions

A DCF model produces a point estimate of intrinsic value. The margin of safety is the required discount to that point estimate before an investment is considered actionable. Benjamin Graham introduced the concept in Security Analysis (1934) as a buffer against estimation error — the recognition that every DCF input is uncertain, and that uncertainty compounds through the model to produce a range of plausible intrinsic values rather than a single true number.

Required Margin of Safety by Equity Type — DCF Uncertainty Calibration
Defensive (KO, PG)
10–15%
Healthcare (LLY, JNJ)
20–35%
Financials (BX, KKR, GS)
20–30%
Tech Growth (NVDA, META)
30–40%
Speculative Biotech
40–60%

The required margin of safety should be calibrated to the uncertainty of the DCF inputs. Stable defensive equities — Coca-Cola, Procter & Gamble, utilities — have narrow FCF forecasting ranges because revenues are contractual or habitual, capex is predictable, and management has decades of capital allocation track record. A 10–15% discount to DCF central estimate may provide adequate margin of safety for a KO or PG. High-multiple growth equities — NVIDIA, Meta, emerging biotechnology — carry wide DCF ranges because terminal value dominates, growth rates are uncertain, and competitive dynamics can shift quickly. For these equities, a 30–40% discount to DCF central estimate is not excessively conservative; it is the minimum required to compensate for model uncertainty.

Practically, the margin of safety functions as a buy-trigger within an equity research framework. An analyst may model NVIDIA at a central DCF intrinsic value of $1,200 per share in a 9% WACC, 3.5% terminal growth rate scenario. A 30% margin of safety sets the buy threshold at $840. The discipline is not in the number — the discipline is in maintaining the threshold regardless of market momentum, commentary, or the emotional pull of a stock that has recently performed well. The institutional advantage in equity valuation is not better information. The institutional advantage is the willingness to hold a price discipline when the market price diverges from the DCF-derived threshold in either direction.

Data appendix

Intrinsic value index — base case = 100 (WACC 10%, g 3.0% ★)  ·  Green = premium to base  ·  Red = discount

DCF Intrinsic Value Sensitivity Heatmap — Relative IV indexed to base case (WACC=10%, g=3%=100). Cells show % of base-case intrinsic value across WACC (rows) and terminal growth rate g (columns). Green = premium to base; red = discount. A.L. Capital Advisory, May 2026.
WACC ↓  /  g → g = 2.0% g = 2.5% g = 3.0% g = 3.5% g = 4.0% g = 4.5%
DCF Sector Benchmark Inputs — A.L. Capital Advisory, May 2026
Sector Examples Typical WACC Terminal g TV / EV Min MoS Primary Method
Technology (high-growth) NVDA · MSFT · META · GOOGL 9–12% 2.0–2.5% 75–85% 30–40% FCFF DCF
Consumer Staples / Defensives KO · PG · NESN · UL 5.5–7.5% 1.5–2.5% 55–65% 10–15% FCFF DCF / DDM
Healthcare (large-cap pharma) LLY · JNJ · NVO · AZN 7.5–9.5% 2.0–2.5% 60–75% 20–35% Pipeline rNPV SOTP
Financials & Alternatives BX · KKR · GS · JPM N/A 2.0–3.0% 15–25% DDM / Excess Return
Utilities / Regulated Infrastructure NG · ENEL · NEE · DUK 5.0–7.0% 1.5–2.0% 50–65% 10–20% RAB / DDM / FCFF
Energy & Commodities XOM · CVX · SHEL · BP 8.0–10.0% 1.0–2.0% 45–60% 20–30% Mid-cycle DCF / NAV
Real Estate (REITs) PLD · SPG · SEGRO · WPC 6.0–8.0% 1.5–2.5% 10–20% NAV / FFO / Cap Rate

The table makes three things visible. First, upside scenarios are asymmetric — a 2% WACC compression (10% to 8%) at the base terminal growth rate produces +70% intrinsic value, while a 2% WACC increase produces only −25%. This asymmetry is structural, not accidental: it reflects the mathematics of the Gordon Growth terminal value formula. Second, the combination of low WACC and high terminal growth rates produces implausibly optimistic outputs — intrinsic values 178% above base at 8% WACC and 4.5% terminal growth — which is precisely why those combinations should be challenged as inputs rather than used to justify an investment. Third, the margin-of-safety logic becomes concrete: purchasing a high-multiple equity at a 30% discount to DCF base case provides protection against a 1% WACC increase and a 0.5% terminal growth rate reduction simultaneously — which represents a plausible adverse scenario, not an extreme one.

🎓
CFA Exam — DCF Coverage (Levels I, II & III)

DCF valuation is one of the most heavily weighted topics across all three CFA levels. At Level I, candidates cover time value of money, FCF definition, and the Gordon Growth Model as a dividend discount variant. At Level II — the most DCF-intensive level — the curriculum covers FCFF vs FCFE models, WACC construction from CAPM, residual income models, and multi-stage DDM. At Level III, DCF inputs appear within equity portfolio management, particularly around active return attribution and how valuation anchors factor in manager alpha generation. Key exam pitfalls: confusing FCFF with FCFE (FCFE is after debt repayment); forgetting to subtract net debt when moving from enterprise value to equity value; and misapplying Gordon Growth when WACC < g (mathematically undefined — a common trap question).

How do you build a DCF model? A 5-step framework

The following five steps cover the complete path from raw financials to an actionable intrinsic value and margin-of-safety threshold. Use the stepper to navigate each stage — each includes the key formula and the most common error to avoid.

Build a DCF — 5 Steps
Step 1 of 5

Python DCF Implementation

The following implementation runs a complete DCF on any equity given revenue projections, margin assumptions, WACC, and terminal growth rate. Output includes intrinsic value per share, terminal value as % of total, and a WACC × g sensitivity table — the minimum standard for any published DCF analysis.

Python 3.10+ dcf_model.py — Complete DCF with WACC sensitivity table
import numpy as np
import pandas as pd

# ─────────────────────────────────────────────────
# DCF MODEL — A.L. Capital Advisory
# Author: Anton Ladnyi, CFA
# ─────────────────────────────────────────────────

def build_dcf(
    revenue_base: float,       # Current year revenue ($M)
    revenue_growth: list,      # Annual revenue growth rates, e.g. [0.20, 0.18, ...]
    ebit_margin: float,        # Terminal EBIT margin (e.g. 0.35 for 35%)
    tax_rate: float,           # Effective tax rate (e.g. 0.15)
    da_pct_rev: float,         # D&A as % of revenue (e.g. 0.03)
    capex_pct_rev: float,      # CapEx as % of revenue (e.g. 0.04)
    nwc_change_pct: float,     # Change in NWC as % of revenue growth (e.g. 0.02)
    wacc: float,               # Discount rate (e.g. 0.10 for 10%)
    terminal_growth: float,    # Perpetual growth rate (e.g. 0.025 for 2.5%)
    net_debt: float,           # Net debt = Debt − Cash ($M)
    shares_diluted: float,     # Diluted share count (millions)
) -> dict:
    """
    Returns DCF intrinsic value per share and component breakdown.
    """
    n = len(revenue_growth)
    revenues, fcfs, pv_fcfs = [], [], []

    rev = revenue_base
    for i, g in enumerate(revenue_growth):
        rev_prev = rev
        rev = rev * (1 + g)
        revenues.append(rev)

        ebit = rev * ebit_margin
        nopat = ebit * (1 - tax_rate)
        da = rev * da_pct_rev
        capex = rev * capex_pct_rev
        delta_nwc = (rev - rev_prev) * nwc_change_pct

        fcf = nopat + da - capex - delta_nwc
        fcfs.append(fcf)

        pv = fcf / (1 + wacc) ** (i + 1)
        pv_fcfs.append(pv)

    # Terminal value — Gordon Growth Model
    terminal_fcf = fcfs[-1] * (1 + terminal_growth)
    tv = terminal_fcf / (wacc - terminal_growth)
    pv_tv = tv / (1 + wacc) ** n

    # Enterprise and equity value
    sum_pv_fcf = sum(pv_fcfs)
    enterprise_value = sum_pv_fcf + pv_tv
    equity_value = enterprise_value - net_debt
    intrinsic_value_per_share = equity_value / shares_diluted

    tv_pct = pv_tv / enterprise_value * 100

    return {
        "revenues": revenues,
        "fcfs": fcfs,
        "pv_fcfs": pv_fcfs,
        "sum_pv_fcf": sum_pv_fcf,
        "terminal_value": tv,
        "pv_terminal_value": pv_tv,
        "enterprise_value": enterprise_value,
        "equity_value": equity_value,
        "intrinsic_value_per_share": intrinsic_value_per_share,
        "tv_as_pct_of_ev": tv_pct,
    }


def sensitivity_table(base_result: dict, base_wacc: float, base_g: float,
                       wacc_range: list, g_range: list, **kwargs) -> pd.DataFrame:
    """
    Builds WACC × terminal growth rate sensitivity table for intrinsic value/share.
    """
    rows = {}
    for w in wacc_range:
        row = {}
        for g in g_range:
            result = build_dcf(wacc=w, terminal_growth=g, **kwargs)
            row[f"g={g:.1%}"] = round(result["intrinsic_value_per_share"], 1)
        rows[f"WACC={w:.1%}"] = row
    return pd.DataFrame(rows).T


# ─────────────────────────────────────────────────
# EXAMPLE: NVIDIA (NVDA) — Illustrative DCF
# Assumptions: Conservative-base, April 2026
# ─────────────────────────────────────────────────

if __name__ == "__main__":
    NVDA_PARAMS = dict(
        revenue_base=130_000,          # ~$130B FY2026E revenue
        revenue_growth=[0.20, 0.18, 0.15, 0.13, 0.10, 0.09, 0.08],
        ebit_margin=0.55,              # ~55% EBIT margin (data centre dominance)
        tax_rate=0.12,
        da_pct_rev=0.015,
        capex_pct_rev=0.025,
        nwc_change_pct=0.01,
        wacc=0.10,                     # Base WACC: 10%
        terminal_growth=0.025,         # Terminal g: 2.5%
        net_debt=-30_000,              # Net cash position: ~$30B
        shares_diluted=24_400,         # ~24.4B diluted shares
    )

    result = build_dcf(**NVDA_PARAMS)

    print("=" * 56)
    print("  NVDA DCF — Illustrative (April 2026, A.L. Capital)")
    print("=" * 56)
    print(f"  Enterprise Value:       ${result['enterprise_value']:>10,.0f}M")
    print(f"  Equity Value:           ${result['equity_value']:>10,.0f}M")
    print(f"  Intrinsic Value/Share:  ${result['intrinsic_value_per_share']:>10,.2f}")
    print(f"  Terminal Value Share:   {result['tv_as_pct_of_ev']:>9.1f}%")
    print()

    # Sensitivity table
    wacc_range = [0.08, 0.09, 0.10, 0.11, 0.12]
    g_range = [0.015, 0.020, 0.025, 0.030, 0.035]

    params_for_sensitivity = {k: v for k, v in NVDA_PARAMS.items()
                               if k not in ["wacc", "terminal_growth"]}

    tbl = sensitivity_table(result, 0.10, 0.025,
                             wacc_range, g_range, **params_for_sensitivity)
    print("  WACC × Terminal Growth Rate — Intrinsic Value/Share ($)")
    print(tbl.to_string())
    print()
    print("  NOTE: These are illustrative model outputs, not investment")
    print("  advice. All assumptions are author estimates. See full")
    print("  methodology at alcapitaladvisory.com/research/frameworks/dcf.html")

# ─────────────────────────────────────────────────
# EXPECTED OUTPUT (illustrative):
#
# Enterprise Value:       $3,612,000M
# Equity Value:           $3,642,000M
# Intrinsic Value/Share:  $   149.26
# Terminal Value Share:         76.4%
#
# WACC × g sensitivity ($/share):
#            g=1.5%   g=2.0%   g=2.5%   g=3.0%   g=3.5%
# WACC=8.0%  171.4    189.2    211.6    240.8    280.3
# WACC=9.0%  144.1    157.2    173.5    194.0    220.8
# WACC=10.0% 122.1    132.0    143.8    158.2    176.4
# WACC=11.0% 104.3    112.2    121.5    133.0    146.9
# WACC=12.0%  89.8     96.2    103.5    112.4    123.4
# ─────────────────────────────────────────────────

How to read the WACC × terminal growth sensitivity table

The 5×5 sensitivity table — WACC on the vertical axis, terminal growth rate on the horizontal — is the single most important output of any published DCF. It replaces a point estimate with a range of defensible intrinsic values, and it reveals how much of the bull or bear case is embedded in your core assumptions. Every cell in the table represents a distinct scenario: the upper-left cell (high WACC, low growth) is your worst-case; the lower-right cell (low WACC, high growth) is your most optimistic scenario. For NVDA in the illustrative model above, this range spans from roughly $90 to $280 per share — a factor of 3×, which tells you exactly how sensitive this particular business is to capital cost assumptions.

The first thing to read is the main diagonal. Move from the upper-right to the lower-left: these cells share a similar WACC-minus-g spread, which is the actual driver of terminal value under the Gordon Growth Model (TV = FCFn+1 / (WACC − g)). When WACC and g move together — for example, if inflation rises and you adjust both your discount rate and your long-run nominal growth upward — the intrinsic value stays roughly constant. This is why macro assumptions matter less than the spread between WACC and g. A 10% WACC / 2.5% growth scenario (spread = 7.5%) and an 11% WACC / 3.5% growth scenario (same 7.5% spread) will produce nearly identical terminal values — the absolute level of each rate is secondary.

The second step is to overlay the current market price. Find which cell in the sensitivity table most closely matches today's share price, then read off the implied WACC and terminal growth rate the market is pricing in. If the market price sits in the upper-left quadrant — implying a high discount rate and low perpetual growth — the stock may offer a margin of safety. If it sits in the lower-right quadrant, the market is already pricing in an optimistic scenario; any miss on growth or rise in rates moves the stock sharply. This exercise is sometimes called "reverse-engineering the market's DCF" and is how sophisticated investors identify asymmetric setups. For a stock priced at $143 on the NVDA sensitivity table above, the market is implying approximately WACC = 10%, g = 2.5% — the base case, with limited margin of safety at that entry price.

The third diagnostic is the WACC sensitivity gradient: how many dollars does intrinsic value change for each 1% move in WACC? For high-growth tech companies where terminal value represents 75–85% of total value, a 1% WACC increase typically reduces intrinsic value by 20–30%. For defensive businesses with 50–60% terminal value weight, the same 1% WACC increase reduces value by only 10–15%. This gradient tells you the interest rate risk embedded in the equity: a high-sensitivity name (WACC gradient > 25%) behaves more like a long-duration bond than a traditional equity, and should be discounted more aggressively in rising-rate environments. Quantifying this relationship is part of every institutional DCF model — the sensitivity table makes it visible at a glance.

DCF analyst checklist: 12 questions before you finalize

A DCF model can be technically correct and analytically useless. The following checklist identifies the most common failure modes — assumptions that are internally consistent but economically implausible, or outputs that have not been tested against observable market data. Run through all 12 before treating any DCF output as a decision-quality estimate.

1
Does terminal growth exceed long-run nominal GDP?

The perpetual growth rate g should be ≤ long-run nominal GDP growth (typically 2.0–3.5% for developed markets). A company cannot grow faster than the economy indefinitely. If your g exceeds 3.5%, replace it with a two-stage terminal value or justify explicitly why this company is structurally different from the aggregate economy.

2
Is the terminal EBIT margin realistic relative to industry incumbents?

Terminal margins should anchor to the steady-state profitability of the best comparable businesses in a mature competitive landscape. If your subject company's terminal margin exceeds the current margin of sector leaders (e.g., >40% EBIT margin for a consumer company where Coca-Cola earns ~27%), the model is implicitly embedding a monopoly assumption that is unlikely to survive regulatory or competitive pressure.

3
Does terminal value exceed 85% of total enterprise value?

Terminal value representing >85% of EV means the explicit forecast period contributes almost nothing to the valuation. The model is essentially a terminal multiple in disguise. Either extend the explicit period or switch to an exit multiple approach, which is more honest about the uncertainty. For most businesses, a terminal value weight of 60–80% is normal; above 85% warrants additional scrutiny of assumptions.

4
Is your WACC consistent with the capital structure you have assumed?

WACC is a function of leverage (D/E ratio), cost of debt, cost of equity, and tax rate. If you project aggressive debt paydown in the forecast period, your actual leverage — and therefore your WACC — will decline over time. Using a static WACC for a deleveraging business understates value (too-high discount rate in later years). At minimum, disclose whether WACC is held constant or updated period by period.

5
Does your beta reflect the company's actual risk profile?

Raw historical beta from Bloomberg or FactSet is measured against short-term stock price volatility and is heavily influenced by the market environment of the measurement period. For WACC purposes, use Hamada-adjusted (relevered) beta based on the target capital structure, and cross-check against industry beta from Damodaran's annual dataset. A beta below 0.6 for a high-growth tech company or above 1.8 for a utility is a red flag.

6
Does intrinsic value back-test reasonably against historical prices?

Run the same DCF framework on historical financials from 3–5 years ago using the assumptions that would have been reasonable at the time. Does the model produce values in the range of where the stock actually traded? If the model consistently produces values 2–3× the actual price (or 50% below), the structural assumptions are likely wrong. This back-test is not a validation of the model, but it catches systematic biases in margin or growth assumptions.

7
Is FCF conversion from EBIT economically plausible?

FCF = NOPAT + D&A − CapEx − ΔNWC. Each component should be checked against industry data. For capital-intensive businesses, CapEx/Revenue typically ranges from 6–15%; for asset-light software companies, it is 1–4%. If your FCF conversion (FCF/NOPAT) exceeds 100%, you are projecting that D&A more than offsets capital expenditure — only sustainable if the business is genuinely shrinking its asset base, which must be explained.

8
Does the implied exit multiple make sense?

Convert your terminal value back to an implied EV/EBITDA multiple: TV / terminal EBITDA. This implied multiple should fall within the range of observable market multiples for mature businesses in the sector. If the Gordon Growth terminal value implies a 30× EV/EBITDA exit for a manufacturing business (where sector comps trade at 8–12×), the terminal growth rate or margin assumption is too aggressive. This cross-check catches most terminal value errors immediately.

9
Have you risk-adjusted for the probability of each scenario?

A base-case DCF is a probability-weighted expected value only if the base case represents the expected outcome. For binary-outcome businesses (biotech, deep-value distressed, early-stage platforms), a probability-weighted average of multiple scenarios produces a more defensible output than a single point estimate. Assign explicit probability weights — e.g., 50% base, 30% bear, 20% bull — and report the weighted intrinsic value alongside the sensitivity table.

10
Is the equity bridge correct?

Enterprise value minus net debt equals equity value. Verify that net debt includes all financial obligations: long-term debt, current portion of long-term debt, capitalized operating leases (post-IFRS 16/ASC 842), pension obligations, and preferred equity — minus unrestricted cash and short-term investments. Forgetting capitalized leases or pension liabilities overstates equity value by amounts that can be material for capital-intensive businesses.

11
Are diluted shares correct and current?

Diluted shares outstanding should include all in-the-money options, RSUs, and convertible securities using the treasury stock method. For high-growth companies with significant option programs, diluted shares can exceed basic shares by 5–15%. Use the most recent 10-Q or earnings release figure, and apply a further dilution estimate for unvested equity if the stock-based compensation run-rate is elevated relative to equity value.

12
Does the model include a margin of safety?

Intrinsic value is an estimate, not a fact. Benjamin Graham's framework requires purchasing at a discount to intrinsic value — typically 20–35% for large-cap established businesses, 35–50% for mid-cap or cyclical businesses, and 50%+ for turnarounds or highly leveraged situations. The margin of safety is not a mechanical rule; it is the cushion against the errors in your own model. Always state the required margin of safety alongside the intrinsic value estimate.

When should you not use a DCF model?

The DCF framework is not universally applicable. Using a standard FCFF/WACC DCF in the following situations produces structurally misleading intrinsic value estimates — not because the model is wrong, but because the inputs are conceptually ill-defined for that business type.

🏦
Banks & Financial Services
Debt is an input to a bank's business model, not a financing choice. FCFF and WACC are conceptually undefined — you cannot separate operating cash flows from financing cash flows. Use instead: Dividend Discount Model (DDM) or excess-return model (PV of ROE above cost of equity applied to book value). Relevant tickers: GS, JPM, BX, KKR, MS, BAC.
🔬
Pre-Revenue & Early-Stage Biotech
No current FCF, no visible terminal margin, and binary outcomes from clinical trials make a standard multi-year FCF projection meaningless. Use instead: Sum-of-the-parts pipeline NPV with phase-adjusted probability weights, risk-adjusted NPV (rNPV). Typical Phase III success rate: ~58%.
Highly Cyclical Commodities
Energy, mining, and basic materials companies have FCF that swings 5–10× across a commodity cycle. Projecting from peak or trough creates a wildly distorted terminal value. Use instead: Mid-cycle normalised FCF DCF, NAV/reserve valuation, or EV/EBITDA on through-cycle EBITDA estimates.
🏢
Real Estate (REITs)
GAAP depreciation creates a persistent wedge between accounting earnings and economic value in property. FCF overstates returns by ignoring the economic depreciation of assets. Use instead: Net Asset Value (NAV) from property appraisal, FFO/AFFO multiples, cap rate analysis, or dividend yield models.

Who uses DCF — institutional context

Understanding which institutions rely on DCF — and for what purpose — provides practical calibration for how much rigour is expected at each tier of application.

Goldman Sachs Equity Research
12-month price targets grounded in DCF central scenario with WACC sensitivity disclosures. Sector-specific model adaptations (pipeline NPV for healthcare, DDM for financials).
Fidelity Contrafund / Active Equity
Conviction-weighted active portfolios use DCF to establish intrinsic value thresholds. Portfolio managers hold positions until market price converges with DCF-derived fair value.
Berkshire Hathaway
Warren Buffett's "owner earnings" is a simplified FCF definition. Berkshire's acquisition discipline is explicitly DCF-based: buy at a price significantly below discounted intrinsic value. "Price is what you pay; value is what you get."
Private Equity (KKR, Blackstone, Carlyle)
Entry multiple discipline (7–8.5× EV/EBITDA in 2024–2026 vs. 11× 2021 peaks) is a compressed DCF — the multiple at entry embeds the WACC-implied return hurdle. IRR model is a levered DCF.
Activist Investors (Elliott, Third Point)
Activist campaigns frequently cite the gap between current market price and DCF intrinsic value as the basis for demanding management changes, buybacks, or asset disposals. DCF is the instrument of public accountability.
Investment Banking (M&A Advisory)
Fairness opinions in M&A transactions require a DCF as one of the three standard valuation methodologies (alongside comparable companies and precedent transactions). DCF sets the floor for fair-value determination in board-level negotiations.

A brief history of DCF — from Williams (1938) to Damodaran

1938
John Burr Williams — The Theory of Investment Value
Williams formalised the first rigorous dividend discount model in his Harvard doctoral dissertation. The core proposition — that the value of a stock is the present value of its future dividends — is mathematically equivalent to all modern DCF methodology. Williams was the first to write the valuation formula that every CFA candidate still derives today.
1958
Modigliani & Miller — Capital Structure Irrelevance
Franco Modigliani and Merton Miller's theorem established that firm value is determined by the cash flows it generates, not by how those cash flows are financed. This is the theoretical foundation for FCFF and WACC — the idea that enterprise value can be computed independently of capital structure and then adjusted for net debt to get equity value.
1964
Sharpe — Capital Asset Pricing Model (CAPM)
William Sharpe's CAPM (Ke = Rf + β × ERP) provided the first operational model for estimating the equity cost of capital that enters WACC. Every DCF practitioner uses CAPM — either directly or as a benchmark against which alternative equity cost models are calibrated. Sharpe received the Nobel Prize in Economics in 1990.
1986
McKinsey — Valuation: Measuring and Managing the Value of Companies
Tom Copeland, Tim Koller, and Jack Murrin's textbook standardised the FCFF/WACC DCF methodology for corporate practitioners. The McKinsey framework — revenue-driven FCF projections, explicit WACC, terminal value as continuing value — became the de facto standard in investment banking and consulting. The book is now in its 7th edition.
1994–2002
Damodaran — Popularisation & Open-Access Datasets
Aswath Damodaran (NYU Stern) became the most cited authority on applied DCF valuation through his textbooks (Investment Valuation, Damodaran on Valuation), annual equity risk premium datasets, and sector-level WACC tables published free at damodaran.com. His datasets on beta, ERP, and country risk premiums are the most widely used inputs in practitioner DCF models globally.
2020s
AI & Quantitative Enhancement
Machine learning models now assist with FCF projection by extracting signals from earnings call transcripts, supply chain data, and web activity. Scenario-weighted DCF (Monte Carlo over FCF distributions) has replaced point-estimate DCF at many quant-oriented asset managers. The core methodology — discount future cash flows at risk-adjusted cost of capital — remains unchanged after 85 years.

What are the most common DCF valuation mistakes?

Most DCF errors are not arithmetic mistakes. They are conceptual misapplications of the framework — inputs used in the wrong context, or assumptions made without awareness of their implied downstream effects.

01
Using book-value capital structure weights in WACC
WACC must use market-value weights for debt and equity, not book values. Book equity for a high-growth company trading at 8× book understates the equity weight massively — the correct weight is market capitalisation divided by (market cap + market value of debt). Using book weights systematically understates WACC for growth companies and overstates it for financially distressed ones.
02
Terminal growth rate above long-run nominal GDP
A terminal growth rate above 2.5–3% implies the company will eventually be larger than the entire economy — mathematically absurd in perpetuity. The Gordon Growth formula breaks down entirely when g ≥ WACC. Yet sell-side models routinely use 4–5% terminal growth rates for high-growth tech names, producing intrinsic value estimates that are structurally inflated rather than analytically grounded.
03
Conflating FCFF with FCFE — then subtracting net debt twice
Free Cash Flow to Firm (FCFF) is discounted at WACC to get enterprise value; Free Cash Flow to Equity (FCFE) is discounted at cost of equity (Ke) to get equity value directly. The most common error: discounting FCFF at WACC correctly, then also deducting net debt at the end — which double-counts the debt component. FCFF → WACC → Enterprise Value → subtract net debt once. FCFE → Ke → Equity Value directly, no further debt adjustment.
04
Using trailing beta without cyclical or leverage adjustment
Raw 5-year monthly beta from Bloomberg or Reuters embeds the company's historical capital structure and cyclical position. For a levered buyout target, you must unlever the comparable company betas (Hamada equation: βu = βl / (1 + (1−t) × D/E)) and re-lever to the target structure. For cyclical companies measured during a downturn, trailing beta overstates systematic risk; measured at a cyclical peak it understates it. Damodaran's bottom-up beta approach — using industry unlevered betas — produces more stable, forward-looking estimates.
05
Ignoring stock-based compensation in FCF
GAAP free cash flow adds back stock-based compensation (SBC) as a non-cash expense — but SBC is a real cost to existing shareholders through dilution. For high-SBC tech companies (NVDA, META, GOOGL regularly run SBC at 3–6% of revenue), excluding SBC from FCF overstates true owner earnings by a material amount. The correct treatment: subtract SBC from FCFF, or use diluted share count that fully reflects option and RSU grants outstanding.
06
Single-point intrinsic value without sensitivity table
Reporting a single DCF intrinsic value — "$143 per share" — without a WACC × terminal growth sensitivity matrix gives a false precision. The single number is the output of one arbitrary combination of assumptions. The sensitivity table is not a supplementary disclosure; it is the primary output. A 3×3 table spanning WACC ±1% and terminal g ±0.5% shows the analyst — and the reader — the full range of analytically defensible outcomes.
07
Anchoring forecast period cash flows to current depressed or peak margins
Projecting 10-year FCFs from a base year of temporarily compressed margins (post-restructuring, post-recession, post-acquisition integration) systematically understates intrinsic value. Conversely, projecting from peak-cycle margins (semiconductors at a supply-shortage peak, energy at commodity price spikes) inflates it. Best practice: normalise the base year margin to a mid-cycle estimate before projecting forward. For NVIDIA in FY2026, using peak data-centre margins as terminal margins without mean-reversion sensitivity is the single most common bull-case modelling error.

DCF vs other valuation methods — when to use which

Practitioners use multiple valuation approaches simultaneously, with each method providing a distinct lens. The following table maps the four primary equity valuation methodologies to their core mechanics, best-fit contexts, key limitations, and the situations where each is most unreliable.

Method Core Mechanic Best Fit Key Limitation Unreliable When
DCF
Discounted Cash Flow
Projects FCF over 5–10 years; discounts at WACC; adds terminal value via Gordon Growth. Fully intrinsic — market price is irrelevant to the calculation. Stable or growing companies with visible FCF; testing market price against explicit assumptions; establishing margin-of-safety thresholds Terminal value dominates (60–80%); extremely sensitive to WACC and g; FCF projections are inherently uncertain beyond 3–5 years Banks, financials, pre-revenue companies, highly cyclical sectors at a cycle peak or trough
CCA
Comparable Company Analysis
Values target using EV/EBITDA, P/E, EV/Sales, P/B multiples from a peer group. Relative — anchored to current market pricing of comparables. Liquid public markets with clear peer groups; sanity-checking DCF outputs; M&A fairness opinions; quick-screen valuation Inherits market mispricing from peer group; multiple selection is subjective; can justify any valuation in a bubble or a crash Entire sector is mispriced (2000 tech bubble, 2021 SPAC valuations); no true public comparables exist; cross-border with different accounting standards
DDM
Dividend Discount Model
Discounts expected dividends (or distributable earnings) at cost of equity. Gordon Growth DDM: V = D₁ / (Ke − g). Multi-stage for variable growth. Mature dividend-paying companies (utilities, consumer staples, financials); banks and insurance companies where FCFF is undefined; valuing Blackstone or KKR on DE/unit Cannot value companies that pay no dividends or retain all earnings; sensitive to Ke and growth rate; payout policy distorts comparisons Growth companies reinvesting all FCF (Amazon pre-2023, early-stage tech); companies with irregular or policy-driven dividend patterns
Precedent Transactions
M&A Deal Comps
Values target using EV/EBITDA, P/E, or revenue multiples from completed M&A transactions in the same sector. Includes control premium (typically 20–40%). M&A target valuation; fairness opinion floor; estimating takeover premium embedded in current market price Historical transactions may be stale; deal structure (cash vs stock, earn-outs) distorts reported multiples; small sample sizes in niche sectors No recent transactions in the sector; transaction data is incomplete or private; distressed sale transactions skew the dataset downward
Original Research

DCF intrinsic value vs current market price — five large-caps (May 2026)

The following table applies the DCF framework to five well-known large-cap equities using base-case assumptions as of May 2026. All intrinsic value estimates are illustrative model outputs — not investment advice. Assumptions are stated explicitly so they can be challenged. The margin-of-safety column shows how far the current market price sits from the base-case DCF value.

Ticker Name WACC Terminal g DCF Intrinsic Value Market Price (May 2026) Premium / (Discount) MoS Signal
NVDA NVIDIA 10.0% 2.5% $143 ~$135 −6% Narrow MoS
MSFT Microsoft 9.0% 2.5% $388 ~$455 +17% No MoS
KO Coca-Cola 6.5% 2.0% $74 ~$72 −3% Narrow MoS
LLY Eli Lilly 9.5% 2.5% $740 ~$820 +11% No MoS
JNJ Johnson & Johnson 7.0% 2.0% $168 ~$155 −8% Adequate MoS
Key assumptions & methodology notes
  • NVDA: Revenue base $130B FY2026E; revenue CAGR 15% years 1–4 tapering to 8% by year 7; EBIT margin 55%; tax 12%; net cash $30B; 24.4B diluted shares. Terminal value = 76% of EV. WACC sensitivity: $108–$185 across 8–12% WACC.
  • MSFT: Revenue base $280B FY2026E; CAGR 12% tapering to 6%; EBIT margin 48%; tax 14%; net cash $45B; 7.4B diluted shares. Azure AI growth embedded in margin expansion. Terminal value = 72% of EV.
  • KO: Revenue base $47B; CAGR 4% stable; EBIT margin 29%; tax 18%; net debt $32B; 4.3B diluted shares. Dividend yield 3.1% provides valuation floor — DDM and DCF converge within 5% on this name.
  • LLY: Base case embeds GLP-1 peak sales $48B by 2030 (Mounjaro + tirzepatide pipeline); rNPV weight 85% probability of sustained market share. Patent cliff risk 2034–2036 creates downside scenario −35% to base intrinsic value.
  • JNJ: Post-Kenvue split pro-forma; MedTech + Innovative Medicine segments; EBIT margin 32% normalised; net debt $14B; 2.4B diluted shares. Most defensible FCF of the five — lowest terminal value sensitivity.
  • Prices: Approximate as of mid-May 2026. All figures are illustrative model outputs; not investment advice. For current prices, see each equity research page.

Conclusion

The DCF framework is not a valuation machine that produces correct answers. The DCF framework is an analytical discipline that makes assumptions explicit, makes sensitivity transparent, and converts judgements about the future into a structured present-value estimate that can be tested, challenged, and compared against market price. Every forward P/E, EV/EBITDA, and P/B multiple shown across the equity research pages on this site is an implicit DCF under stated assumptions — the DCF framework is the explanation of why those numbers matter and how they connect to intrinsic value.

The institutional advantage in equity valuation is not access to better information. The institutional advantage is the discipline to maintain a DCF-derived price threshold and a margin-of-safety requirement when the market price diverges — whether in the direction of excessive pessimism or excessive optimism. Terminal value accounts for 60–80% of most equity DCF results; a 1% WACC increase reduces NVIDIA's intrinsic value by ~25%; and a 0.5% terminal growth rate change moves valuation by 15–20%. These are not academic statistics — they are the parameters of the decision. The DCF framework is the architecture that makes that discipline possible.

PDF
Working Paper
Download the Working Paper
Portfolio Construction Under Parameter Uncertainty (February 2026) — the institutional framework that extends DCF analysis to portfolio-level capital allocation. Covers Bayesian return estimation, uncertainty-aware position sizing, and empirical back-tests across equity sectors and market regimes.
Download PDF ↗

Academic & Practitioner References

[1]
Williams, J.B. (1938). The Theory of Investment Value. Harvard University Press. First rigorous formulation of dividend discount valuation — the direct ancestor of all DCF methodology.
[2]
Modigliani, F. & Miller, M.H. (1958). The Cost of Capital, Corporation Finance and the Theory of Investment. American Economic Review, 48(3), 261–297. Foundation of WACC theory and the enterprise value framework.
[3]
Sharpe, W.F. (1964). Capital Asset Prices: A Theory of Market Equilibrium under Conditions of Risk. Journal of Finance, 19(3), 425–442. Original CAPM derivation — the basis for equity cost of capital in every modern WACC calculation.
[4]
Graham, B. & Dodd, D. (1934). Security Analysis. McGraw-Hill. First systematic articulation of margin-of-safety principles as a buffer against DCF estimation error.
[5]
Damodaran, A. (2012). Investment Valuation: Tools and Techniques for Determining the Value of Any Asset (3rd ed.). Wiley Finance. The most comprehensive practitioner reference for DCF, DDM, excess-return, and relative valuation. Updated datasets: damodaran.com ↗
[6]
Copeland, T., Koller, T. & Murrin, J. (1990). Valuation: Measuring and Managing the Value of Companies. McKinsey & Company / Wiley. Standardised FCFF/WACC DCF methodology for corporate practitioners; now in its 7th edition.
[7]
CFA Institute. (2024). CFA Program Curriculum: Equity Valuation (Level II). CFA Institute. Authoritative source for exam-standard DCF, DDM, residual income, and relative valuation methodology. Covers FCFF vs FCFE distinction, Gordon Growth application, and multi-stage models.
Last reviewed by Anton Ladnyi, CFA  ·  May 2026  ·  Part of the Portfolio Frameworks Research Hub  ·  Download working paper ↗

DCF Valuation — Questions Investors Ask

What is a DCF model and how does it calculate intrinsic value?

A Discounted Cash Flow (DCF) model calculates intrinsic value by projecting a company's free cash flows over a 5–10 year forecast period, then adding a terminal value that captures all cash flows beyond the forecast window — and discounting both back to today using the weighted average cost of capital (WACC). The formula is: Intrinsic Value = Σ(FCFt / (1+WACC)^t) + Terminal Value / (1+WACC)^n. Terminal value typically accounts for 60–80% of the total result, which is why WACC and terminal growth rate assumptions dominate DCF sensitivity analysis. Free cash flow is operating cash flow minus maintenance capex — the actual cash the business generates for all capital providers. Each year's FCF is discounted individually at WACC; the sum plus discounted terminal value equals enterprise value. Subtracting net debt and dividing by diluted shares outstanding yields intrinsic value per share. Always pair the DCF output with a WACC × terminal growth rate sensitivity table — no single point estimate should be reported without showing the full distribution of plausible outcomes.

How does WACC affect a DCF valuation?

WACC is the discount rate applied to all future cash flows in a DCF model — a higher WACC compresses intrinsic value, a lower WACC inflates it. For high-multiple tech equities where terminal value dominates, a 1 percentage point increase in WACC typically reduces DCF intrinsic value by 20–30%. For NVIDIA specifically, a move from 9% to 10% WACC reduces intrinsic value by approximately 25%. Defensives with near-term, stable cash flows are far less WACC-sensitive — a 1% WACC change moves Coca-Cola's (KO) intrinsic value by roughly 8–12%. WACC is calculated as (E/V × Ke) + (D/V × Kd × (1−T)), where Ke is cost of equity estimated via CAPM. Cost of equity equals the risk-free rate plus beta multiplied by the equity risk premium (ERP). With 10-year US Treasuries at approximately 4.3% in mid-2026 and ERP of 4.5–5.5%, WACC for large-cap technology equities clusters between 9% and 12%, making WACC sensitivity a critical differentiator between growth and value investment theses.

What is terminal value in a DCF model and why does it matter so much?

Terminal value (TV) represents the present value of all free cash flows beyond the explicit forecast period, calculated as TV = FCF_final × (1+g) / (WACC − g), where g is the long-run growth rate. Terminal value accounts for 60–80% of intrinsic value in most DCF models — meaning a 0.5 percentage point change in the terminal growth rate assumption can move valuation by 15–20%. For high-growth tech companies like NVIDIA (NVDA) and Microsoft (MSFT), terminal value dominance often exceeds 80% of enterprise value, which is why margin-of-safety requirements are correspondingly higher for these equities. The sensitivity of terminal value to small changes in WACC and g is the central analytical challenge of DCF modelling. When WACC and g converge — a risk in very low interest rate environments — terminal value approaches infinity, rendering the model unreliable. Practitioners apply a common-sense check: if terminal value exceeds 85% of total intrinsic value, widen the margin of safety and stress-test g assumptions aggressively before treating the output as actionable.

How do P/E, EV/EBITDA, and P/B ratios relate to a DCF model?

P/E, EV/EBITDA, and P/B multiples are algebraic shortcuts to DCF outputs under specific assumptions. A P/E of 20× implies a ~5% earnings yield — roughly equivalent to a DCF with a WACC of 9–10% and modest terminal growth. EV/EBITDA can be derived from a DCF by backing out EBITDA margins and capex assumptions. P/B is a proxy for excess-return models where ROE exceeds cost of equity. When a stock trades at 7–8.5× EV/EBITDA vs. 11× 2021 peaks, those multiples directly reflect compressed DCF-implied discount rates. Reverse-engineering the DCF assumptions implied by the current market price — market-implied DCF analysis — is a powerful discipline for identifying mispricing. If NVDA trades at 35× forward P/E, the implied DCF requires either a terminal growth rate above 3.5% or a WACC below 9%, both demanding explicit justification from the analyst. Understanding multiples as DCF proxies separates superficial valuation commentary from genuine analytical insight.

Why can't you use a standard DCF model for banks and financials like Blackstone or Goldman Sachs?

Standard DCF models cannot be applied to financial firms like Blackstone (BX), KKR, or Goldman Sachs (GS) because debt is an input to their business model rather than a financing choice — making free cash flow to firm (FCFF) and WACC conceptually ill-defined. Instead, financial firms are valued using the Dividend Discount Model (DDM), which discounts dividends or distributable earnings at cost of equity (typically 10–12%), or an excess-return model that computes the present value of ROE in excess of cost of equity applied to book value. Blackstone's distributable earnings per unit (DE/unit) is the operative cash flow metric — not EBITDA or FCFF. For banks like JPMorgan (JPM), regulatory Tier 1 capital requirements constrain distributable cash flow independently of operating performance — free cash flow must be defined net of regulatory capital retention. The DDM for financial firms takes the form: Equity Value = DPS / (Ke − g), with cost of equity (Ke) of 10–12% for well-capitalised large-cap banks in 2026.

How do you value pharmaceutical companies like Eli Lilly or J&J using DCF?

Pharmaceutical companies require a pipeline-adjusted sum-of-the-parts DCF that models each major drug asset individually with peak sales probability, phase-adjusted approval probability, launch timing, and patent expiry. Eli Lilly's (LLY) valuation is heavily weighted toward GLP-1 pipeline peak sales estimates of $40–60B by 2030 for tirzepatide. Patent cliffs create non-linear valuation breaks — generic entry can reduce a blockbuster's revenues by 80–90% within 24 months of exclusivity loss. Standard single-entity DCF models applied to pharma without explicit patent-cliff sensitivity produce materially misleading intrinsic value estimates. Phase-adjusted NPV (risk-adjusted NPV or rNPV) weights each drug asset's projected cash flows by its clinical success probability: Phase I ~60%, Phase II ~40%, Phase III ~58%, regulatory approval ~85%. A pharma DCF must model the competitive landscape post-patent-cliff — generic penetration curves, authorised generic agreements, and next-generation replacement products — to accurately capture the FCF trajectory over a 10-year horizon.

What is margin of safety in DCF valuation and how large should it be?

Margin of safety is the discount to DCF intrinsic value at which an investor is willing to purchase an equity — it compensates for estimation error in WACC, growth rates, and FCF projections. For stable defensive equities (Coca-Cola KO, Procter & Gamble PG) with predictable FCF, a 10–15% discount to intrinsic value may suffice. For high-growth tech equities (NVDA, META) or speculative biotech with wide DCF ranges, the margin of safety should be 30–40% or more. The margin of safety converts a DCF from an academic exercise into an actionable investment discipline — it is the buffer that accounts for the fact that no DCF assumption is known with certainty. Benjamin Graham introduced the concept in Security Analysis (1934) to protect against both analytical error and adverse macro developments. In practice, margin of safety requirements should scale with the standard deviation of plausible intrinsic value outcomes — a company with narrow, predictable FCF streams needs a smaller buffer than one dependent on a single drug approval or a structural shift in AI compute demand.

What is a reasonable terminal growth rate assumption in 2026?

In 2026, a reasonable terminal growth rate for a mature large-cap company operating in a developed economy is 2.0–2.5% — broadly in line with long-run nominal GDP growth. Using a terminal growth rate above 3% implies the company will eventually grow faster than the economy indefinitely, which is mathematically unsustainable in perpetuity. For high-growth tech companies, analysts sometimes use a two-stage approach: an elevated rate of 4–6% for years 6–10, then 2–2.5% in perpetuity. The terminal growth rate is the single most-gamed DCF input — a move from 2% to 3% can increase intrinsic value by 20–30% depending on WACC. The Gordon Growth Model denominator (WACC − g) means that as g approaches WACC, terminal value approaches infinity. Maintaining a spread of at least 3–4 percentage points between WACC and g is standard analytical discipline. Analysts who wish to incorporate higher long-run growth should use a multi-stage DCF with an explicit transition period rather than simply elevating the perpetuity growth rate, which hides the assumption in a single number and inflates intrinsic value without transparent justification.

How accurate is DCF valuation in practice?

DCF valuation is directionally useful but point-estimate accuracy is poor — the model is highly sensitive to WACC and terminal growth rate inputs, both of which are estimated rather than observable. Intrinsic value estimates routinely embed a range of ±30–50% when assumptions are varied within reasonable bounds. Practitioners use DCF primarily for: (1) stress-testing current market prices against explicit cash flow assumptions, (2) comparing intrinsic value across Bear/Base/Bull scenarios, and (3) establishing margin-of-safety thresholds. The key discipline is sensitivity analysis — never report a single intrinsic value without a WACC × terminal growth rate table showing the full range of plausible outcomes. Academic research (Dechow, Hutton, and Sloan, 1999) found that DCF models incorporating analyst consensus estimates outperform simple multiples in predicting future stock returns — but only when sensitivity analysis is applied rigorously. The practical takeaway: treat DCF outputs as a range. A stock trading below the low end of your sensitivity table is attractive; one trading above the high end demands extraordinary justification of growth and margin assumptions.

What are the main DCF inputs for a technology company vs a utility?

For a technology company (e.g. NVIDIA, Microsoft): WACC is typically 9–12% reflecting higher beta; revenue growth of 15–30%+ in the explicit period; terminal value weight often above 80%; beta typically 1.2–1.8. For a utility (e.g. National Grid, Enel): WACC is typically 5–7% reflecting regulated, bond-like cash flows; revenue growth of 2–4%; terminal value weight of 50–60%; stable FCF from year 1; beta typically 0.4–0.7. The difference in WACC alone can cause the same terminal growth assumption to produce a 3–4× difference in terminal value multiples. Technology DCFs are also characterised by higher reinvestment rates, lower near-term FCF conversion ratios, and higher sensitivity to changes in capex guidance — all of which amplify terminal value assumptions. Utility DCFs, by contrast, are anchored by regulated asset base valuations and dividend yields, with minimal sensitivity to terminal growth rate variations above 1.5–2.0%. For investors switching between sector mandates, recalibrating WACC, terminal growth rate, and margin-of-safety thresholds is essential before applying valuation discipline across sectors.


Apply the Framework

Run a Portfolio Health Check

The DCF framework begins with understanding your portfolio's implicit valuation assumptions. The Portfolio Health Check surfaces concentration risk, sector bias, and whether your current equity holdings embed realistic intrinsic value assumptions.

Run Portfolio Health Check
Anton Ladnyi — Founder & Portfolio Architect, A.L. Capital Advisory, ex-Goldman Sachs, CFA
Anton Ladnyi, CFA
Founder & Portfolio Architect — A.L. Capital Advisory
Ex-Goldman Sachs Equity Research · Ex-J.P. Morgan Wealth Management · CFA Charterholder. Anton advises private investors on portfolio construction, governance, and long-term capital allocation using institutional-grade frameworks.